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Hypereosinophilia as first clinical presentation has rarely been reported in paediatric acute lymphoblastic leukaemia.
It is commonly associated with specific cytogenetic abnormalities. Although eosinophilia is considered a reactive,
non-neoplastic epiphenomenon, it adversely affects patient outcomes, both in children and adults. We describe
herewith two paediatric patients who had marked eosinophilia at onset of acute lymphoblastic leukaemia. We point
out the importance of a correct differential diagnosis in persistent, unexplained peripheral hypereosinophilia.
Clinicians should keep in mind that eosinophilia can be part of the overall pattern of acute leukaemia and therefore
needs to be properly investigated. We also provide some recommendations for an appropriate approach to
hypereosinophilia - related morbidities.
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Hypereosinophilia is frequently documented with parasitic
infections, allergic disorders, and some haematologic malig-
nancies, including acute lymphoblastic and chronic myeloid
leukaemias, and Hodgkin’s lymphoma [1].
The association of acute lymphoblastic leukaemia (ALL)
and hypereosinophilia represents a distinct clinico-patho-
logical entity [2-4], although rarely described in childhood
[2,5,6], with 44 paediatric cases reported to date [7]. In
these patients, presenting symptoms are non-specific and
include intermittent low-grade fever, fatigue and “purpuric”
rash [8]. Although hypereosinophilia has commonly been
interpreted as a reactive epiphenomenon rather than the re-
sult of a leukemic clone [9], its occurrence appears to be as-
sociated with worse prognosis, both in children [6] and
adults [10]. Cytogenetic abnormalities, such as t(5;14), are
commonly associated with this subtype of leukaemia [9].
We report herewith two paediatric cases of eosinophilia
at diagnosis of acute lymphoblastic leukaemia, presenting* Correspondence: rparasol64@gmail.com
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unless otherwise stated.to our institution almost simultaneously, thus raising the
question of a possible common etiology.Case presentations
Case 1. B.V.
A 13-year-old girl was referred in June 2011 to our Institu-
tion for persistent low-grade fever and fatigue. On
admission, physical examination was negative except for
noticeable swelling of the inferior left leg, that Doppler
ultrasound documented to be secondary to deep venous
thrombosis of the left iliac-femoral axis. Laboratory findings
showed a normal leukocyte count (WBC 7,870/μL)
with marked hypereosinophilia (44.3%), mild anemia (Hb
9.8 g/dL) and thrombocytopenia (129,000/μL). Peripheral
blood smears revealed mature eosinophils and no abnormal
cells. Main parasitic infections and allergic conditions were
ruled out. Bone marrow aspirates showed a prevalence
of FAB L2 lymphoblasts (52%) associated with 30%
of eosinophilic elements. Immunophenotyping revealed
CD10-positive blasts of B-lymphoid lineage, with cytogen-
etic analysis showing normal 46, XX karyotype. Molecular
diagnostic studies detected clonal rearrangement of the im-
munoglobulin heavy-chain (IgH) region, while the main
molecular leukaemic rearrangements, including bcr/abl,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sion genes, turned negative [11].
Patient was enrolled in the AIEOP-BFM ALL 2000
protocol [12], excluding L-Asparaginase (L-ASP), given the
concomitant venous thrombosis for which enoxaparin was
instituted. Following the 8-day prednisone pre-phase ther-
apy, marked drop of peripheral eosinophil count was evi-
dent. At day 15, bone marrow was free of blast cells.
Thrombophilic profile documented genetic predisposition
to thrombosis consisting of homozygous for -455G/A of b-
fibrinogen (Table 1). At day 78, patient was assigned to
intermediate risk for minimal residual disease, measured by
real-time quantitative polymerase chain reaction (PCR)
[13]. At the end of induction, the thrombotic pattern had
disappeared, but enoxaparin prophylaxis was continued
until maintenance. Consolidation therapy was well tolerated
and during re-induction therapy, L-ASP was administered
without any adverse effects. Presently, at 7 months from
end of therapy and 31 months from diagnosis, patient is in
complete continuous remission.Table 1 Patients’ clinical features and laboratory results
Characteristics Patient #1
Sex Female
Age at diagnosis 13 years
Peripheral blood:
Hb (g/dL) 9.8
White blood cells count (μL) 7,870
Eosinophils count (μL)(%) 3,490 (44.3%)








Bone marrow biopsy B cells lymphoproliferative
(WHO grading)
Karyotype 46, XX
Molecular biology for ALL rearrangements Negative
Molecular biology for thrombophilia Positive (Homozygous for
Clinical presentation Evening fever
Left iliac-femoral deep ven
Other organ involvement No
FAB, French-American-British classification; MF, myelofibrosis; WHO, world health orCase 2. R.S.
In July 2011, fifteen days after the previous patient’s admis-
sion, a 20 month-old boy with recent history of viral illness
(hand-foot-mouth disease), followed by the appearance of
an erythematous papular rash (pruritic erythroderma),
fever, night sweats and claudication for left inferior limb
arthralgia, was referred to us for consultation. Blood count
showed mildly increased white blood cell count (WBC
14,390/μL) with hypereosinophilia (4,620/μL). Peripheral
blood smears showed marked hypereosinophilia with 2% of
immature cells (Figure 1a). Laboratory investigations were
negative for parasitic infections and allergic diseases.
Bone marrow aspirates revealed a prevalence (60%) of L1
CALLA positive lymphoblasts with 36% eosinophils (36%)
(Figure 1b). The histologic examination of a cutaneous le-
sion showed infiltration by leukaemic cells associated with
eosinophilia (Figure 1c). Computerized tomography (CT)
of left inferior limb documented a tibial osteolytic area with
interruption of cortical bone profile (Figure 1d); histologi-





















Claudication for left inferior limb arthralgia
Skin
Bone (tibial osteolysis)
ganization; HPA, human platelet antigen; ALL, acute lymphoblastic leukaemia.
Figure 1 Patients’ hematopathology and radiology. a) Peripheral smear showing lymphoblasts and eosinophils (May-Grünwald -Giemsa); b)
Bone marrow smear showing FAB L1-lymphoblasts, eosinophils and neutrophils (May-Grünwald - Giemsa); c) Skin biopsy showing perivascular
infiltration of small lymphocytes and eosinophils (Hematoxylin-eosin, original magnification × 100); Inset: lymphocyte’s nuclear TdT positivity in
immunohistochemistry (ABC staining, × 400); d) CT scan demonstrating tibial osteolytic area with interruption of cortical bone profile.
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karyotype (52 chromosomes), while the main leukaemic re-
arrangements, including bcr/abl, Jak2 and 4q(12) [11] were
negative (Table 1). Treatment with the AIEOP-BFM ALL
2000 protocol [12] was initiated, leading to prompt
response to prednisone on day 8. On day 15, patient
was in complete haematological remission. To prevent
hypereosinophilia-related thrombotic complications, pro-
phylactic enoxaparin was administered until the end of the
induction phase, with transient interruptions when platelet
count lowered to < 30,000/μL. The thrombophylic profile
showed genetic predisposition to thrombosis (Table 1). Fol-
lowing results of PCR that showed negativity of both
markers at day 33 and 78, patient was assigned to standard-
risk [13]. Consolidation and re-induction phases were per-
formed without complications. Presently, patient remains
in full continuous remission, six months after conclusion of
maintenance therapy. Patient’s clinical features and labora-
tory results are listed in Table 1.
Discussion and conclusions
Less than 1% of children with ALL present with hyper-
eosinophilia at time of diagnosis [14]. These cases areprevalently male patients, median age at presentation of
14 years (range, 2–58). The ALL is mostly characterized
by a B-lineage phenotype [15-17]. Eosinophilia generally
precedes the diagnosis of ALL by 1 to 9 months and
quickly resolves with achievement of disease remission,
but tends to accompany relapse, if it occurs. Although
several hypotheses have been proposed [16], whether
this reappearance is due to leukaemia or to an associated
infection remains unclear.
In this report, we have described 2 pediatric cases, pre-
senting to us within a 15 day interval, with eosinophilia
as first clinical presentation of ALL. Of note, in the
series of 341 ALL patients diagnosed in our institution
and enrolled in the ALL-2000 protocol in a 10-year
period, only these 2 patients had hypereosinophilia at
onset. Our findings might suggest that eosinophilia is a
reactive condition to some pathogen, such as seasonal
infection. In fact, patient # 2 had a positive history for
recent viral illness (hand-foot-mouth disease). Other in-
vestigators have demonstrated the non-clonal origin of
eosinophils in ALL [1-6,9,10], but further cytogenetic
and molecular studies are required to confirm these ob-
servations, given the rarity of this association. A possible
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lia could be the production by leukemic cells of stimulat-
ing eosinophilic factors, such as interleukin 3 (IL-3) or
IL-5 [9,14]. Other exogenous factors, ie viral infections,
could contribute to cytokine production with subsequent
hypereosinophilia.
Some cytogenetic abnormalities, frequently reported in
precursor B-acute lymphoblastic leukaemia associated with
marked eosinophilia, [1,4,9] could be involved in the com-
plex mechanism of leukaemogenesis, [9] or in over-
expression of eosinophil growth factors. The most common
cytogenetic findings involve chromosomes 5 and 14, t(5;14)
(q31;q32) and chromosome 5 deletion, del(5)(q15q33). Of
interest, chromosome 5 carries IL-3 gene, whose overex-
pression leads to increased eosinophil production [14].
Cytogenetic abnormalities were found only in leukaemic
blasts while eosinophils presented normal karyotype in 90%
of the cases [9]. Nevertheless, the relationship between
eosinophilia and leukaemia remain controversial. In the
two patients reported herein, no characteristic chromo-
somal abnormalities were observed, with hyperdiploidy in
patient # 2, not involving chromosome 5.
The persistence of peripheral hypereosinophilia should
still lead the clinician to exclude an idiopathic hypereosi-
nophilic syndrome (HES), a clonal proliferation second-
ary to a myeloproliferative disorder with obvious
prognostic and therapeutic implications [18]. Therefore,
the presence of specifically molecular genetic abnormal-
ity FIP1L1–PDGFRA fusion gene, is in favour of the hy-
pothesis that this haematological disorder represents a
chronic eosinophilic leukaemia. In case a persistent eo-
sinophilia is documented, diagnosis of HES must ruled
out. Our patients were both negative for 4q(12) re-
arrangement, as well as for Jack2 and brc/abl.
Prognosis of ALL presenting with hypereosinophilia is
definitely worse both in children [6] and adults [10], with
median survival of 7.5 months [15]. With the limitations of
a short follow-up (30-months median survival), both our
patients are in haematological and molecular continuous
complete remission.
In patients bearing this association, a significantly in-
creased risk of cardiac and vascular thrombosis exists
[19]. Congestive heart failure represents the main cause
of mortality in patients with ALL and hypereosinophilia
[15,19]. We observed a thrombotic complication at diag-
nosis in patient # 1, successfully resolved with anticoagu-
lant therapy. Clinicians should therefore keep in mind
that thrombotic complications may occur in this ALL
subset in order to plan prompt heparin prophylaxis or
chemotherapic modulation of prothrombotic drugs, such
as L-ASP.
Pruritic erythroderma represents an additional com-
mon presenting feature in children with ALL and hyper-
eosinophilia [9]. In this regard, patient # 2 showed adiffuse itchy erythematous-papular erythroderma at on-
set, misdiagnosed even by expert dermatologists. There-
fore, skin biopsy is a mandatory procedure in case of
cutaneous lesions of difficult differential diagnosis in
order to confirm a possible infiltration by malignant cells
(Figure 1c).
In conclusion, the poor prognosis reported for these atyp-
ical ALL should prompt clinicians to carry out accurate
follow-up including peripheral eosinophil count that could
be the first manifestation of relapsed leukaemia. In addition,
this unique ALL form presents additional morbidity and
mortality related to hypereosinophilia, such as cardiac fail-
ure, peripheral neuropathy and thromboembolic phenom-
ena. Follow-up should therefore include careful surveillance
of secondary complications.
Based on our experience, we suggest that paediatri-
cians and haematologists should be aware of this un-
usual presentation of ALL within the context of a
correct differential diagnosis of persistent peripheral eo-
sinophilia, particularly in the absence of lymphoblasts in
peripheral blood. We point out that persistent hypereo-
sinophilia may occur together with ALL also in the ab-
sence of anemia, thrombocytopenia and leukocytosis,
thus requiring appropriate investigation, including bone
marrow aspirate [20].Consent
Written informed consent was obtained from patients’ par-
ents for publication of these Case reports and any accom-
panying images. A copy of the consent form is available for
appraisal by the Editor-in-Chief.
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